Evaluation of efficacy and risks of vaccination for liver transplant recipients

Evaluation of efficacy and risks of vaccination for liver transplant recipients - Vaccination for liver transplant recipients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000030485

Enrollment

200

Registered

2018-12-20

Start date

2018-12-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver transplant recipients

Interventions

Vaccination for patients with immunosuppressant measles rubella mumps varicella each 1 time

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: More than 2 years after transplantation Without steroid administration More than 1 year with stable liver functional tests

Exclusion criteria

Exclusion criteria: Without inclusion criteria With active infection

Design outcomes

Primary

Measure	Time frame
Obtain immunity from vaccination 12 months after vaccination (IgG)	—

Secondary

Measure	Time frame
Side effects of vaccination within 12months after vaccination	—

Countries

Japan

Contacts

Public ContactHideaki OKAJIMA

Graduate School of Medicine Kyoto University Division of Hepato-Biliary-Pancreatic surgery

ho1962@kuhp.kyoto-u.ac.jp075-751-3243

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026